Top

Published in:

01-07-2020 | Stroke | Case report

Eptacog-α

Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports

Published in: Reactions Weekly | Issue 1/2020

Excerpt

In a retrospective and observational study of 63 patients, who received eptacog-α between 1 September 2015 and 30 June 2017, 4 patients [ages and sexes not stated] were described, who developed deep-vein thrombosis (DVT), ischaemic stroke or transient ischaemic attack (TIA) during treatment with eptacog-α for the reversal of anticoagulation-associated bleeding or refractory bleeding in cardiac surgery [dosages and routes not stated; not all times to reactions onsets and outcomes stated]. …

Marsh K, et al. Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven) utilization at a large academic medical center. Therapeutic Advances in Cardiovascular Disease 14: 14 May 2020. Available from: URL: http://doi.org/10.1177/1753944720924255

Title: Eptacog-α
Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports
Publication date: 01-07-2020
Publisher: Springer International Publishing
Keywords: Stroke
Heart Surgery
Heart Surgery
Warfarin
Thrombosis
Heparin
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-80345-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Eptacog-α

Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Immune globulin

Adalimumab/infliximab

Dextromethorphan

Clozapine

Cisplatin/fluorouracil

Levodopa/carbidopa